OBLONE
LIVE

Serial Number

79187402

Owner

BIOFARMA

Attorney

Leslie Bertagnolli

Filing Date

Mar 17, 2016

Add to watchlist:

No watchlists yet
View on USPTO

OBLONE Trademark

Serial Number: 79187402 • Registration: 5298666

OBLONE is a trademark filed by BIOFARMA on March 17, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

BIOFARMA (296 trademarks)

50, rue Carnot
Suresnes cedex 92284 , FR

Entity Type: 03

Trademark Details

Filing Date

March 17, 2016

Registration Date

October 3, 2017

Published for Opposition

July 18, 2017

Cancellation Date

February 17, 2025

Goods & Services

Pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of osteoporosis; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; dietary supplements, namely, enzyme food supplements, vitamin and mineral food supplements, herbal food supplements and trace element food supplements and dietetic foods adapted for medical use, namely, pasta and crackers, bars, powdered milk, pollen, amino acids and beverages; medical plasters used as material for dressings for medical purposes; wound dressings; medicated compresses for use in application of implants; teeth filling material; dental impression materials; disinfectants; preparations for destroying noxious animals; fungicides; herbicides; all the aforementioned goods for diabetic, oncological and osteoporotic fields, excluding veterinary products

Implantable drug delivery systems for the treatment and prevention of diabetes; implantable drug delivery systems for the treatment and prevention of cancer; implantable drug delivery systems for the treatment and prevention of osteoporosis; medical apparatus and instruments for use in surgery for application of implants; applicators for medications and applicators for pharmaceutical use, namely, droppers for use in application of implants; injection devices for pharmaceuticals; medical implants in the nature of drug delivery systems; pharmaceutical implants in the nature of drug delivery systems; drug delivery systems for medical use in delivering pharmaceuticals from containers; infusion pumps to deliver medication; all the aforementioned goods for diabetic, oncological and osteoporotic fields, excluding veterinary products

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sep 5, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Sep 5, 2025 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 21, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 18, 2025 INTS
INVALIDATION PROCESSED
Feb 18, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 20, 2024 INTR
CANCELLED SECTION 71
Apr 19, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 3, 2022 REM3
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 5, 2019 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Jan 25, 2019 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 16, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 18, 2018 FICS
FINAL DISPOSITION PROCESSED
Jan 18, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 3, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 3, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 15, 2017 PREV
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 7, 2017 TCCA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 7, 2017 ERFR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 10, 2017 LIMN
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 30, 2017 GNFN
FINAL REFUSAL E-MAILED
Mar 30, 2017 GNFR
FINAL REFUSAL WRITTEN
Mar 30, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2017 CRFA
ASSIGNED TO LIE
Mar 10, 2017 ALIE
NOTICE OF REVIVAL - MAILED
Feb 23, 2017 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2017 TROA
PETITION TO REVIVE-GRANTED
Feb 23, 2017 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 23, 2017 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 25, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 25, 2017 ABN2
LIMITATION OF GOODS RECEIVED FROM IB
Jan 20, 2017 LIMG
REFUSAL PROCESSED BY IB
Jul 15, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 29, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jun 29, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 29, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jun 28, 2016 CNRT
ASSIGNED TO EXAMINER
Jun 28, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 14, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 2, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 2, 2016 SDRC